Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Life Sciences Solutions Segment by Year
Life Sciences Solutions Segment (Total Segment Revenue) ($M)
Thermo Fisher Scientific Life Sciences Solutions Segment: $10,374M in FY2025, up 7.7% from a year earlier.
Where the FY2025 figure comes from
“LSS: Revenues 2,341 2,499 2,588 2,946 10,374 2,636 2,815 2,719”
Source: Q3 2026 Reconciliation of Financial Information ↗
Includes 3 operating businesses: Biosciences, Genetic Sciences, and BioProduction.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Life Sciences Solutions Segment (Total Segment Revenue) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10,374 | +7.7% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 9,631 | -3.5% | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 9,977 | -26.3% | Q4 & FY2024 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 13,532 | – | SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗ |
Breakdown
What makes up life Sciences Solutions Segment
- Biosciences (Molecular Biology Reagents, Cell Culture & Protein)4,169 · FY2025
- Genetic Sciences (Gene Sequencing, qPCR & Genetic Analysis)2,870 · FY2025
- BioProduction (Single-Use Bioproduction Systems & Consumables)3,200 · FY2025
- Other / Intersegment Eliminations — Life Sciences Solutions Segment136 · FY2025
Cite this data
StockData. (2026). Thermo Fisher Scientific Life Sciences Solutions Segment ($M), annual FY2022–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-seg-lss
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.